207 related articles for article (PubMed ID: 12368358)
1. Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81.
Drummer HE; Wilson KA; Poumbourios P
J Virol; 2002 Nov; 76(21):11143-7. PubMed ID: 12368358
[TBL] [Abstract][Full Text] [Related]
2. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.
Tian ZF; Shen H; Fu XH; Chen YC; Blum HE; Baumert TF; Zhao XP
World J Gastroenterol; 2009 Jan; 15(2):240-4. PubMed ID: 19132776
[TBL] [Abstract][Full Text] [Related]
3. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.
Higginbottom A; Quinn ER; Kuo CC; Flint M; Wilson LH; Bianchi E; Nicosia A; Monk PN; McKeating JA; Levy S
J Virol; 2000 Apr; 74(8):3642-9. PubMed ID: 10729140
[TBL] [Abstract][Full Text] [Related]
4. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
[TBL] [Abstract][Full Text] [Related]
5. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor.
Masciopinto F; Campagnoli S; Abrignani S; Uematsu Y; Pileri P
Virus Res; 2001 Nov; 80(1-2):1-10. PubMed ID: 11597743
[TBL] [Abstract][Full Text] [Related]
6. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
Drummer HE; Boo I; Maerz AL; Poumbourios P
J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241
[TBL] [Abstract][Full Text] [Related]
7. Binding of hepatitis C virus to CD81.
Pileri P; Uematsu Y; Campagnoli S; Galli G; Falugi F; Petracca R; Weiner AJ; Houghton M; Rosa D; Grandi G; Abrignani S
Science; 1998 Oct; 282(5390):938-41. PubMed ID: 9794763
[TBL] [Abstract][Full Text] [Related]
8. Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.
Drummer HE; Wilson KA; Poumbourios P
Biochem Biophys Res Commun; 2005 Mar; 328(1):251-7. PubMed ID: 15670777
[TBL] [Abstract][Full Text] [Related]
9. Small molecule inhibition of hepatitis C virus E2 binding to CD81.
VanCompernolle SE; Wiznycia AV; Rush JR; Dhanasekaran M; Baures PW; Todd SC
Virology; 2003 Sep; 314(1):371-80. PubMed ID: 14517089
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
Patel AH; Wood J; Penin F; Dubuisson J; McKeating JA
J Gen Virol; 2000 Dec; 81(Pt 12):2873-2883. PubMed ID: 11086118
[TBL] [Abstract][Full Text] [Related]
11. Cell fusion activity of hepatitis C virus envelope proteins.
Takikawa S; Ishii K; Aizaki H; Suzuki T; Asakura H; Matsuura Y; Miyamura T
J Virol; 2000 Jun; 74(11):5066-74. PubMed ID: 10799580
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of hepatitis C virus envelope-CD81 binding.
Petracca R; Falugi F; Galli G; Norais N; Rosa D; Campagnoli S; Burgio V; Di Stasio E; Giardina B; Houghton M; Abrignani S; Grandi G
J Virol; 2000 May; 74(10):4824-30. PubMed ID: 10775621
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.
Flint M; Maidens C; Loomis-Price LD; Shotton C; Dubuisson J; Monk P; Higginbottom A; Levy S; McKeating JA
J Virol; 1999 Aug; 73(8):6235-44. PubMed ID: 10400713
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity.
Chan-Fook C; Jiang WR; Clarke BE; Zitzmann N; Maidens C; McKeating JA; Jones IM
Virology; 2000 Jul; 273(1):60-6. PubMed ID: 10891408
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into hepatitis C virus receptor binding and entry.
Kumar A; Hossain RA; Yost SA; Bu W; Wang Y; Dearborn AD; Grakoui A; Cohen JI; Marcotrigiano J
Nature; 2021 Oct; 598(7881):521-525. PubMed ID: 34526719
[TBL] [Abstract][Full Text] [Related]
16. Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface.
Forns X; Allander T; Rohwer-Nutter P; Bukh J
Virology; 2000 Aug; 274(1):75-85. PubMed ID: 10936090
[TBL] [Abstract][Full Text] [Related]
17. [Structural biology of human CD81, a receptor for hepatitis C virus].
Kitadokoro K
Uirusu; 2004 Jun; 54(1):39-47. PubMed ID: 15449903
[TBL] [Abstract][Full Text] [Related]
18. Subunit association and conformational flexibility in the head subdomain of human CD81 large extracellular loop.
Kitadokoro K; Ponassi M; Galli G; Petracca R; Falugi F; Grandi G; Bolognesi M
Biol Chem; 2002 Sep; 383(9):1447-52. PubMed ID: 12437138
[TBL] [Abstract][Full Text] [Related]
19. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
20. Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity.
Fenouillet E; Lavillette D; Loureiro S; Krashias G; Maurin G; Cosset FL; Jones IM; Barbouche R
J Biol Chem; 2008 Sep; 283(39):26340-8. PubMed ID: 18667425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
